Moises Rivera Jr. filed his complaint on October 9 in the federal GLP-1 vision loss MDL, joining hundreds of similar failure-to-warn claims now in front of Judge Karen Marston.
Recap by typeshit. Full story at AboutLawsuits.com.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
The quip points at muscle loss during GLP-1 weight loss. Frigon says patients are told to add milk protein to help hold on to muscle.
Piotr Alvarez says HILIC flips elution order for semaglutide and tirzepatide, helping catch impurities, while TFA faces likely PFAS limits.
Loading…